These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 2165223

  • 1. [Use in hemodialysis and hemofiltration of CY 216 (Fraxiparine) administered via intravenous bolus in patients with acute and chronic renal insufficiency with and without hemorrhagic risk].
    Steinbach G, Bosc C, Caraman PL, Azoulay E, Olry L, D'Azemar P, Chopin J.
    Nephrologie; 1990; 11(1):17-21. PubMed ID: 2165223
    [Abstract] [Full Text] [Related]

  • 2. [Anticoagulation in hemodialysis sessions with a low molecular weight heparin (CY 222, Choay). Dosage studies in chronic hemodialysis. Its use in patients at high risk of hemorrhage].
    Dieval J, Morinière P, Roussel B, Bayrou B, Fournier A, Delobel J.
    J Mal Vasc; 1987; 12 Suppl B():114-8. PubMed ID: 2834482
    [Abstract] [Full Text] [Related]

  • 3. [Use of the low-molecular heparin, Fraxiparine, during hemodialysis].
    Monhart V, Petrů K.
    Cas Lek Cesk; 1998 Jan 12; 137(1):18-21. PubMed ID: 9511272
    [Abstract] [Full Text] [Related]

  • 4. [Prevention of thrombogenesis in the extracorporeal circuit of hemodialysis with a low molecular heparin: standardization of the dosage with a better hemorrhagic risk/effectiveness ratio].
    Barata JD, Oliveira C, Bruges M, Gusmão L, Santana A, Ponce P, Simões J, Freire I, Crespo F, da Silva AN.
    Acta Med Port; 1992 Feb 12; 5(2):65-70. PubMed ID: 1317657
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of acute pulmonary embolism with a low molecular weight heparin by the intravenous route. Study of the optimal dosage].
    Quilliet L, Charbonnier B, Delahousse B, Gruel Y, Brochier ML, Leroy J, Toulemonde F.
    Arch Mal Coeur Vaiss; 1988 Oct 12; 81(10):1219-25. PubMed ID: 2851965
    [Abstract] [Full Text] [Related]

  • 6. [The use of enoxaparine for anticoagulation in extracorporeal circulation in hemodialysis at high risk for hemorrhage].
    Dechelette E, Pouzol P, Jurkovitz C, Kuentz F, Polack B, Cuzin E, Woler M.
    J Mal Vasc; 1987 Oct 12; 12 Suppl B():105-7. PubMed ID: 2834479
    [Abstract] [Full Text] [Related]

  • 7. Low molecular weight heparin (CY-216) versus unfractionated heparin in chronic hemodialysis.
    Grau E, Sigüenza F, Maduell F, Linares M, Olaso MA, Martinez R, Caridad A.
    Nephron; 1992 Oct 12; 62(1):13-7. PubMed ID: 1331831
    [Abstract] [Full Text] [Related]

  • 8. Anticoagulant-free Genius haemodialysis using low molecular weight heparin-coated circuits.
    Frank RD, Müller U, Lanzmich R, Groeger C, Floege J.
    Nephrol Dial Transplant; 2006 Apr 12; 21(4):1013-8. PubMed ID: 16326745
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The clinical evaluation of low-dose heparin in haemodialysis: a prospective study using the heparin-coated AN69 ST membrane.
    Chanard J, Lavaud S, Maheut H, Kazes I, Vitry F, Rieu P.
    Nephrol Dial Transplant; 2008 Jun 12; 23(6):2003-9. PubMed ID: 18156457
    [Abstract] [Full Text] [Related]

  • 11. Low molecular weight heparin and haemodialysis: neutralization by protaminchloride.
    Andrassy K.
    Blood Coagul Fibrinolysis; 1993 Dec 12; 4 Suppl 1():S39-43. PubMed ID: 8180328
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Parameters of hemostasis during treatments associating fractionated heparin administered subcutaneously to standard and fractionated heparin administered intravenously in the chronic hemodialysis patient].
    Morinière P, Diéval J, Roussel B, Gross S, Bayrou B, Delobel J, Fournier A.
    Nephrologie; 1990 Dec 12; 11(3):141-6. PubMed ID: 2234270
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Use of a low molecular weight heparin, CY 222, in the treatment of consumption coagulopathy].
    Audibert G, Lambert H, Toulemonde F, Alexandre P, Laprevote-Heully MC, Bollaert PE, Bauer P, Larcan A.
    J Mal Vasc; 1987 Dec 12; 12 Suppl B():147-51. PubMed ID: 2834489
    [Abstract] [Full Text] [Related]

  • 17. Low-molecular-weight heparin Fraxiparin in chronic hemodialysis. A dose-finding study.
    Morinière P, Dieval J, Bayrou B, Roussel B, Renaud H, Fournier A, Delobel J.
    Blood Purif; 1989 Dec 12; 7(6):301-8. PubMed ID: 2558691
    [Abstract] [Full Text] [Related]

  • 18. A low molecular weight heparin ("fragmin") for routine hemodialysis: a crossover trial comparing three dose regimens with a standard regimen of commercial unfractionated heparin.
    Anastassiades E, Lane DA, Ireland H, Flynn A, Curtis JR.
    Clin Nephrol; 1989 Dec 12; 32(6):290-6. PubMed ID: 2558829
    [Abstract] [Full Text] [Related]

  • 19. Equivalent effective doses of heparin and low molecular weight heparin(oid)s in haemodialysis for chronic renal failure.
    Lane DA, Ireland H, Tew CJ, Flynn A, Curtis JR.
    Acta Chir Scand Suppl; 1988 Dec 12; 543():101-4. PubMed ID: 2847457
    [Abstract] [Full Text] [Related]

  • 20. Continuous hemofiltration with a low molecular weight heparin, enoxaparine: report on two cases.
    Lorenzini JL, Freysz M, Honnart D, Zeller V, Dutrillaux F.
    Int J Clin Pharmacol Ther Toxicol; 1991 Mar 12; 29(3):89-91. PubMed ID: 1649141
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.